Live-Animal Epigenome Editing: Convergence of Novel Techniques

J. Antonio Gomez, Ulrika Beitnere, David Segal

Research output: Contribution to journalReview article

Abstract

Epigenome editing refers to the generation of precise chromatin alterations and their effects on gene expression and cell biology. Until recently, much of the efforts in epigenome editing were limited to tissue culture models of disease. However, the convergence of techniques from different fields including mammalian genetics, virology, and CRISPR engineering is advancing epigenome editing into a new era. Researchers are increasingly embracing the use of multicellular model organisms to test the role of specific chromatin alterations in development and disease. The challenge of successful live-animal epigenomic editing will depend on a well-informed foundation of the current methodologies for cell-specific delivery and editing accuracy. Here we review the opportunities for basic research and therapeutic applications.

Original languageEnglish (US)
JournalTrends in Genetics
DOIs
StatePublished - Jan 1 2019

Fingerprint

Chromatin
Clustered Regularly Interspaced Short Palindromic Repeats
Therapeutic Human Experimentation
Virology
Epigenomics
Cell Biology
Research Personnel
Gene Expression

Keywords

  • animal models
  • cancer
  • CRISPR
  • delivery
  • epigenomic editing
  • neurodevelopment

ASJC Scopus subject areas

  • Genetics

Cite this

Live-Animal Epigenome Editing : Convergence of Novel Techniques. / Gomez, J. Antonio; Beitnere, Ulrika; Segal, David.

In: Trends in Genetics, 01.01.2019.

Research output: Contribution to journalReview article

@article{23e98130b62d4fe0aeb79f68b410221f,
title = "Live-Animal Epigenome Editing: Convergence of Novel Techniques",
abstract = "Epigenome editing refers to the generation of precise chromatin alterations and their effects on gene expression and cell biology. Until recently, much of the efforts in epigenome editing were limited to tissue culture models of disease. However, the convergence of techniques from different fields including mammalian genetics, virology, and CRISPR engineering is advancing epigenome editing into a new era. Researchers are increasingly embracing the use of multicellular model organisms to test the role of specific chromatin alterations in development and disease. The challenge of successful live-animal epigenomic editing will depend on a well-informed foundation of the current methodologies for cell-specific delivery and editing accuracy. Here we review the opportunities for basic research and therapeutic applications.",
keywords = "animal models, cancer, CRISPR, delivery, epigenomic editing, neurodevelopment",
author = "Gomez, {J. Antonio} and Ulrika Beitnere and David Segal",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.tig.2019.04.007",
language = "English (US)",
journal = "Trends in Genetics",
issn = "0168-9525",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Live-Animal Epigenome Editing

T2 - Convergence of Novel Techniques

AU - Gomez, J. Antonio

AU - Beitnere, Ulrika

AU - Segal, David

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Epigenome editing refers to the generation of precise chromatin alterations and their effects on gene expression and cell biology. Until recently, much of the efforts in epigenome editing were limited to tissue culture models of disease. However, the convergence of techniques from different fields including mammalian genetics, virology, and CRISPR engineering is advancing epigenome editing into a new era. Researchers are increasingly embracing the use of multicellular model organisms to test the role of specific chromatin alterations in development and disease. The challenge of successful live-animal epigenomic editing will depend on a well-informed foundation of the current methodologies for cell-specific delivery and editing accuracy. Here we review the opportunities for basic research and therapeutic applications.

AB - Epigenome editing refers to the generation of precise chromatin alterations and their effects on gene expression and cell biology. Until recently, much of the efforts in epigenome editing were limited to tissue culture models of disease. However, the convergence of techniques from different fields including mammalian genetics, virology, and CRISPR engineering is advancing epigenome editing into a new era. Researchers are increasingly embracing the use of multicellular model organisms to test the role of specific chromatin alterations in development and disease. The challenge of successful live-animal epigenomic editing will depend on a well-informed foundation of the current methodologies for cell-specific delivery and editing accuracy. Here we review the opportunities for basic research and therapeutic applications.

KW - animal models

KW - cancer

KW - CRISPR

KW - delivery

KW - epigenomic editing

KW - neurodevelopment

UR - http://www.scopus.com/inward/record.url?scp=85065877686&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065877686&partnerID=8YFLogxK

U2 - 10.1016/j.tig.2019.04.007

DO - 10.1016/j.tig.2019.04.007

M3 - Review article

C2 - 31128888

AN - SCOPUS:85065877686

JO - Trends in Genetics

JF - Trends in Genetics

SN - 0168-9525

ER -